Answers are grounded in this paper and cite their sources.
The clinical therapy of pancreatic cancer (PC) is severely limited by its dense tumor stroma and the persistence of cancer stem cells (CSCs). Here, we report the use of small-sized micelles co-encapsulating indocyanine green and the CSC inhibitor napabucasin (mICG-Nap), which integrate photothermal ablation with stemness suppression to address these dual barriers. Upon near-infrared (NIR) irradiation, mICG-Nap greatly increased photothermal cytotoxicity and suppressed CSC-associated clonogenicity in PC cells. Systemic administration of mICG-Nap plus NIR irradiation effectively repressed tumors in both the PANC-1 and stroma-rich SW1990 xenograft models. To further improve tumor delivery in dense pancreatic tumors, mICG-Nap was upgraded with dual-targeting peptides recognizing plectin-1 and α v β 3 integrin (T-mICG-Nap), resulting in enhanced tumor accumulation and retention and deep tissue penetration. Consequently, T-mICG-Nap combined with NIR achieved superior photothermal efficacy, more effective CSC suppression, and significantly prolonged survival in SW1990-bearing mice, extending the median survival time to 111 days (compared with 30 days for PBS and 76 days for the non-targeted control). Overall, this micellar integration of photothermal ablation with CSC inhibition has appeared to be a potent therapeutic strategy for treating PC.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: